Eden Research plc Result of AGM (5414E)
30 Junio 2023 - 3:17AM
UK Regulatory
TIDMEDEN
RNS Number : 5414E
Eden Research plc
30 June 2023
30 June 2023
Eden Research
("Eden" or "the Company")
Result of Annual General Meeting
Eden Research plc (AIM: EDEN), the AIM-quoted company focused on
sustainable biopesticides and plastic-free formulation technology
for use in the global crop protection, animal health and consumer
products industries, is pleased to announce that all resolutions
put forward to shareholders at the Company's Annual General Meeting
held yesterday were duly passed.
The total number of votes received by proxy on each resolution,
as more fully disclosed in the Notice of Meeting available on the
Company's website, was as follows:
Resolution For % Against % Withheld
#
To lay the 2022 Annual
1 Report 131,946,591 100 - - 180,000
------------------------- ------------ ------ -------- ----- ---------
2 Re-appoint auditors 131,921,591 99.98 25,000 0.02 180,000
------------------------- ------------ ------ -------- ----- ---------
3 Elect Richard Horsman 131,812,391 100 - - 314,200
------------------------- ------------ ------ -------- ----- ---------
4 Re-elect Robin Cridland 131,901,591 100 - - 225,000
------------------------- ------------ ------ -------- ----- ---------
Grant authority to
the Directors to allot
5 Ordinary Shares 131,904,060 99.86 186,281 0.14 36,250
------------------------- ------------ ------ -------- ----- ---------
Disapply statutory
pre-emption rights
6 on allotment of shares* 131,756,753 99.72 363,588 0.28 6,250
------------------------- ------------ ------ -------- ----- ---------
Notes:
-- * denotes Special Resolution.
-- A vote Withheld is not a vote in law and is not counted in
the calculation of the votes cast For or Against the resolution,
nor in the calculation of the percentage of issued share capital
voted for any resolution.
-- Votes For and Against are expressed as a percentage of votes
validly cast for that resolution by proxy, excluding any Withheld
votes.
For further information contact:
Eden Research plc www.edenresearch.com
Sean Smith
Alex Abrey 01285 359 555
Cenkos Securities plc (Nominated advisor
and broker)
Giles Balleny / Max Gould (corporate
finance)
Michael Johnson (sales) 020 7397 8900
Hawthorn Advisors (Financial PR)
Simon Woods eden@hawthornadvisors.com
Felix Meston
Notes to Editors:
Eden Research is the only UK-listed company focused on
biopesticides for sustainable agriculture. It develops and supplies
innovative biopesticide products and natural microencapsulation
technologies to the global crop protection, animal health and
consumer products industries.
Eden's products are formulated with terpene active ingredients,
based on natural plant defence metabolites. To date, they have been
primarily used on high-value fruits and vegetables, improving crop
yields and marketability, with equal or better performance when
compared with conventional pesticides. Eden has two products
currently on the market:
Based on plant-derived active ingredients, Mevalone (R) is a
foliar biofungicide which initially targets a key disease affecting
grapes and other high-value fruit and vegetable crops. It is a
useful tool in crop defence programmes and is aligned with the
requirements of integrated pest management programmes. It is
approved for sale in a number of key countries whilst Eden and its
partners pursue regulatory clearance in new territories thereby
growing Eden's addressable market globally.
Cedroz (TM) is a bionematicide that targets free living
nematodes which are parasitic worms that affect a wide range of
high-value fruit and vegetable crops globally. Cedroz is registered
for sale on two continents and Eden's commercial collaborator,
Eastman Chemical, is pursuing registration and commercialisation of
this important new product in numerous countries globally.
Eden's Sustaine(R) encapsulation technology is used to harness
the biocidal efficacy of naturally occurring chemicals produced by
plants (terpenes) and can also be used with both natural and
synthetic compounds to enhance their performance and ease-of-use.
Sustaine microcapsules are naturally-derived, plastic-free,
biodegradable micro-spheres derived from yeast. It is one of the
only viable, proven and immediately registerable solutions to the
microplastics problem in formulations requiring encapsulation.
Eden was admitted to trading on AIM on 11 May 2012 and trades
under the symbol EDEN. It was awarded the London Stock Exchange
Green Economy Mark in January 2021, which recognises London-listed
companies that derive over 50% of their total annual revenue from
products and services that contribute to the global green economy.
Eden derives 100% of its total annual revenues from sustainable
products and services.
For more information about Eden, please visit: www.edenresearch.com .
Follow Eden on LinkedIn , Twitter and YouTube .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGFMMPTMTBJMJJ
(END) Dow Jones Newswires
June 30, 2023 04:17 ET (08:17 GMT)
Eden Research (LSE:EDEN)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Eden Research (LSE:EDEN)
Gráfica de Acción Histórica
De May 2023 a May 2024
